CoChat

Cardiac troponin I as diagnostic and prognostic marker in severe heart failure

La Vecchia, Luigi, Mezzena, Gabriella, Zanolla, Luisa, Paccanaro, Mariemma, Varotto, Leonardo, Bonanno, Carlo, Ometto, Renato · 2000 · The Journal of Heart and Lung Transplantation

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

Background Cardiac cell death has been shown to occur in heart failure and has been implicated as one of the mechanisms responsible for progression of the disease. Cardiac Troponin I (cTnI) represents a highly sensitive marker for myocardial cell death. Based on previous studies reporting that cTnI may be detected in patients with heart failure, we evaluated the clinical correlates and prognostic implications of detectable cTnI in a consecutive series of patients with severe heart failure.Methods Thirty-four patients were examined. Upon admission, we measured serum levels of cTnI by conventional immunoenzymatic assay (Stratus Dade II). According to the results of this assay, patients were divided into 2 groups, based on the presence (cTnI+) or absence (cTnI-) of detectable cTnI. These 2 groups were compared by non-parametric analysis for their clinical characteristics, instrumental findings, and short-term outcome.Results The cTnI+ group included 10 patients (29%) with a mean serum cTnI of 0.7 +/- 0.3 ng/ml. Compared with the cTnI- group, these patients had significantly lower left ventricular ejection fractions (20% +/- 5% vs 26% +/- 7%, p = 0.023) and a trend for higher systolic pulmonary artery pressure (59 +/- 17 mm Hg vs 49 +/- 13 mm Hg, p = 0.08). In cTnI+ patients, the correlation between cTnI levels upon admission and ejection fraction was r = -0.530 (p = 0.11). We found ischemic etiology was equally present in the 2 groups, whereas we never found histologic signs of acute myocarditis. Other clinical characteristics (functional class, daily diuretic dose, need for intravenous inotropes) were not statistically different in the 2 groups. In cTnI+ patients who improved after admission, cTnI became undetectable after a few days; in patients with refractory heart failure who were hospitalized until death, cTnI persisted in detectable levels throughout the observation period. Using the Cox proportional hazard model, a positive cTnI was the most powerful predictor of mortality at 3 months (p = 0.013; hazard ratio 6.86; 95% confidence interval 1.32 to 35.4).Conclusions These observations suggest that cTnI is detected in the blood of 25% to 33% of patients with severe heart failure; its presence may help to identify a high-risk sub-group who faces very poor short-term prognosis.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1053-2498(00)00120-0

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 46 references

Research works printed but not linked: 3

  1. Latif, 1998, Analysis of apoptosis in dilated cardiomyopathy, Eur Heart J, 19, 648
  2. Aretz, 1986, Myocarditis, Am J Cardiovasc Pathol, 1, 3
  3. Isaaz, 1999, Altered coronary blood flow velocity reserve in dilated cardiomyopathy results from both increased baseline velocity and inappropriate intramyocardial coronary dilatory capacity, J Am Coll Cardiol, 33, 507A

Cited by

See all 191

Metadata

Authors
La Vecchia, L., Mezzena, G., Zanolla, L., Paccanaro, M., Varotto, L., Bonanno, C., & Ometto, R.
Affiliations
Ospedale San Bortolo (IT)
Venue
The Journal of Heart and Lung Transplantation
Publisher
Elsevier BV
Published
2000-07
Volume
19
Issue
7
Pages
644-652
ISSN
1053-2498 (ISSN-L)
OpenAlex
W1993630991
Cited by
191
References
46
Citations by year
2025: 3 · 2024: 3 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 10 · 2016: 2 · 2015: 8 · 2014: 8 · 2013: 8 · 2012: 12
FWCI
5.44
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The Journal of Heart and Lung Transplantation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Keywords
cardiac troponin I, severe heart failure, myocardial cell death, prognostic factors, mortality prediction, left ventricular ejection fraction, refractory heart failure, ischemic heart failure, acute myocarditis, short-term outcomes, serum biomarkers, pulmonary artery pressure, inotrope requirement, diuretic dose, functional class, disease progression, myocardial fibrosis
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Biopsy, Female, Cardiac Catheterization, Heart Failure, Humans, Male, Myocardium, Prognosis, Prospective Studies, Severity of Illness Index, Fluoroimmunoassay, Biomarkers, Coronary Angiography, Echocardiography, Doppler, Color, Troponin I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. https://app.cochat.ai/papers/10.1016/s1053-2498(00)00120-0
The paper
La Vecchia, L., Mezzena, G., Zanolla, L., Paccanaro, M., Varotto, L., Bonanno, C., & Ometto, R. (2000). Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. The Journal of Heart and Lung Transplantation. https://doi.org/10.1016/s1053-2498(00)00120-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.